NCT04511663
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- Shanghai Mental Health Center Shanghai, China
Clinical trial condition
Schizophrenia Spectrum and Other Psychotic Disorders
Explore clinical trials studying Schizophrenia Spectrum and Other Psychotic Disorders. Study availability and eligibility vary by location and protocol.
3,091 public trials
348 recruiting studies
Schizophrenia Spectrum and Other Psychotic Disorders trial results
Completed
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
NCT03345979
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- Alkermes Investigational Site Little Rock, Arkansas, United States
- Alkermes Investigational Site Rogers, Arkansas, United States
- Alkermes Investigational Site Cerritos, California, United States
- Alkermes Investigational Site Culver City, California, United States
NCT03164876
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- King's College London Institute of Psychiatry, Psychology and Neuroscience (IoPPN) London, United Kingdom
NCT03485339
- Conditions
- Chemically-Induced Disorders, Disease Attributes, Disease Susceptibility, +11 more
- Locations
-
- Queen Mary Hospital Hong Kong
- Western Psychiatric Centre Hong Kong
Completed
Thinking Skills at Work: Cognitive Remediation Therapy for Patients With Serious Mental Illness
NCT03483701
- Conditions
- Mental Disorders, Psychotic Disorder, Psychotic Disorders, +3 more
- Locations
-
- Fraser Health: Royal Columbian Hospital New Westminster, British Columbia, Canada
NCT03317132
- Conditions
- Mental Disorders, Psychosis, Psychotic Disorders, +1 more
- Locations
-
- Fraser Health: Royal Columbian Hospital New Westminster, British Columbia, Canada
Completed
Avatar Therapy in Comparison to Cognitive Behavioral Therapy for Treatment-resistant Schizophrenia
NCT03585127
- Conditions
- Auditory Hallucination, Verbal, Hallucinations, Mental Disorders, +10 more
- Locations
-
- Institut Universitaire en Santé Mentale de Montréal Montreal, Quebec, Canada
- Conditions
- First Episode Psychosis, Mental Disorders, Psychotic Disorders, +3 more
- Locations
-
- Clinical Trial Site Chertsey, United Kingdom
- Clinical Trial Site London, United Kingdom
- Clinical Trial Site Newcastle upon Tyne, United Kingdom
- Clinical Trial Site Oxford, United Kingdom
NCT03610087
- Conditions
- Cardiovascular Risk Factor, Mental Disorders, Metabolic Disease, +5 more
- Locations
-
- Centre for Addiction and Mental Health Toronto, Ontario, Canada
NCT03285503
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- Beijing Anding Hospital of Capital Medical University Beijing, Beijing Municipality, China